Business Description
PEPTONIC medical AB
ISIN : SE0005962206
Compare
Compare
Traded in other countries / regions
PMED.Sweden28L.Germany IPO Date
2014-06-30Description
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.02 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.55 | |||||
| Beneish M-Score | -1.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 82.8 | |||||
| 3-Year EBITDA Growth Rate | 7.3 | |||||
| 3-Year EPS without NRI Growth Rate | 3 | |||||
| 3-Year FCF Growth Rate | -7.8 | |||||
| 3-Year Book Growth Rate | -30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.3 | |||||
| 9-Day RSI | 25.95 | |||||
| 14-Day RSI | 25.79 | |||||
| 6-1 Month Momentum % | -42.11 | |||||
| 12-1 Month Momentum % | -45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.76 | |||||
| Quick Ratio | 1.38 | |||||
| Cash Ratio | 0.65 | |||||
| Days Inventory | 310.79 | |||||
| Days Sales Outstanding | 65.23 | |||||
| Days Payable | 137.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.3 | |||||
| Shareholder Yield % | 15.45 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.34 | |||||
| Operating Margin % | -70.06 | |||||
| Net Margin % | -76.51 | |||||
| FCF Margin % | -101.68 | |||||
| ROE % | -44.62 | |||||
| ROA % | -33.74 | |||||
| ROIC % | -37.35 | |||||
| ROC (Joel Greenblatt) % | -238.45 | |||||
| ROCE % | -36.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.26 | |||||
| PB Ratio | 0.24 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | -0.74 | |||||
| EV-to-EBITDA | -0.86 | |||||
| EV-to-Revenue | 0.47 | |||||
| EV-to-FCF | -0.44 | |||||
| Price-to-Net-Current-Asset-Value | 0.76 | |||||
| Earnings Yield (Greenblatt) % | -134.39 | |||||
| FCF Yield % | -176.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
PEPTONIC medical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 40.521 | ||
| EPS (TTM) (kr) | -0.048 | ||
| Beta | 0.2 | ||
| Volatility % | 72.79 | ||
| 14-Day RSI | 25.79 | ||
| 14-Day ATR (kr) | 0.005464 | ||
| 20-Day SMA (kr) | 0.02814 | ||
| 12-1 Month Momentum % | -45 | ||
| 52-Week Range (kr) | 0.0108 - 0.129 | ||
| Shares Outstanding (Mil) | 1,534.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PEPTONIC medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PEPTONIC medical AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
PEPTONIC medical AB Frequently Asked Questions
What is PEPTONIC medical AB(XSAT:PMED)'s stock price today?
The current price of XSAT:PMED is kr0.02. The 52 week high of XSAT:PMED is kr0.13 and 52 week low is kr0.01.
When is next earnings date of PEPTONIC medical AB(XSAT:PMED)?
The next earnings date of PEPTONIC medical AB(XSAT:PMED) is 2024-05-07.
Does PEPTONIC medical AB(XSAT:PMED) pay dividends? If so, how much?
PEPTONIC medical AB(XSAT:PMED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers